PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21634377-0	2011	Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.	Formaldehyde	90-98	sodium voltage-gated channel alpha subunit 9	Rattus norvegicus	57-63	
21634377-1	2011	Clinical human genetic studies have recently identified the tetrodotoxin (TTX) sensitive neuronal voltage gated sodium channel Nav1.7 (SCN9A) as a critical mediator of pain sensitization.	Tetrodotoxin	60-72	sodium voltage-gated channel alpha subunit 9	Homo sapiens	127-133	
21634377-1	2011	Clinical human genetic studies have recently identified the tetrodotoxin (TTX) sensitive neuronal voltage gated sodium channel Nav1.7 (SCN9A) as a critical mediator of pain sensitization.	Tetrodotoxin	60-72	sodium voltage-gated channel alpha subunit 9	Homo sapiens	135-140	
21634377-1	2011	Clinical human genetic studies have recently identified the tetrodotoxin (TTX) sensitive neuronal voltage gated sodium channel Nav1.7 (SCN9A) as a critical mediator of pain sensitization.	Tetrodotoxin	74-77	sodium voltage-gated channel alpha subunit 9	Homo sapiens	127-133	
21634377-1	2011	Clinical human genetic studies have recently identified the tetrodotoxin (TTX) sensitive neuronal voltage gated sodium channel Nav1.7 (SCN9A) as a critical mediator of pain sensitization.	Tetrodotoxin	74-77	sodium voltage-gated channel alpha subunit 9	Homo sapiens	135-140	
21634377-2	2011	Herein, we report structure-activity relationships for a novel series of 2,4-diaminotriazines that inhibit hNav1.7.	2,4-diaminotriazine	73-93	sodium voltage-gated channel alpha subunit 9	Homo sapiens	107-114